Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SOLARA ACTIVE PHARMA SCIENCES Plunges 3%; BSE HEALTHCARE Index Up 0.6%
Wed, 3 Jul 10:1

SOLARA ACTIVE PHARMA SCIENCES Plunges 3%; BSE HEALTHCARE Index Up 0.6%Image source: peterschreiber.media/www.istockphoto.com

SOLARA ACTIVE PHARMA SCIENCES share price has plunged 3% and is presently trading at Rs 566.9.

Meanwhile, the BSE HEALTHCARE index is at 37,374.6 (up 0.6%).

Among the top losers in the BSE HEALTHCARE index today are AARTI DRUGS (down 1.1%) and Jubilant Pharmova (down 1.0%).

FORTIS HEALTHCARE (up 2.5%) and Cadila Healthcare (up 2.4%) are among the top gainers today.

Over the last one year, SOLARA ACTIVE PHARMA SCIENCES has moved up from Rs 359.2 to Rs 566.9, registering a gain of Rs 207.7 (up 57.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,627.6 to 37,374.6, registering a gain of 45.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 93.3%), Cadila Healthcare (up 90.3%) and GSK Pharma (up 87.3%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,039.7 (up 0.8%).

The top gainers among the BSE Sensex today are HDFC Bank (up 2.9%) and ICICI Bank (up 1.9%). The most traded stocks in the BSE Sensex are HDFC Bank and SBI.

In the meantime, NSE Nifty is at 24,273.2 (up 0.6%). HDFC Bank and Axis Bank are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,205.1 to 80,039.7, registering a gain of 14,834.7 points (up 22.8%).

SOLARA ACTIVE PHARMA SCIENCES Financial Update...

SOLARA ACTIVE PHARMA SCIENCES net profit fell 6912.0% YoY to Rs -2,555 million for the quarter ended March 2024, compared to a profit of Rs 38 million a year ago. Net sales declined 21.3% to Rs 2,994 million during the period as against Rs 3,806 million in January-March 2023.

For the year ended March 2023, SOLARA ACTIVE PHARMA SCIENCES reported 61.8% increase in net profit to Rs -223 million compared to net loss of Rs 583 million during FY22. Revenue of the company grew 13.8% to Rs 14,438 million during FY23.

The current Price to earnings ratio of SOLARA ACTIVE PHARMA SCIENCES, based on rolling 12 month earnings, stands at -4.8.


Equitymaster requests your view! Post a comment on "SOLARA ACTIVE PHARMA SCIENCES Plunges 3%; BSE HEALTHCARE Index Up 0.6%". Click here!